Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Caporali

Showing results (1-10 of 416) with videos related to

Pageof 42
Sort By:
Nature Reviews. Rheumatology|April 2, 2024
Author Correction: Proposals for the rheumatological use of JAK inhibitorsFrancesco Ciccia, Roberto Caporali
Clinical and Experimental Rheumatology|September 6, 2018
Real-world experience with tofacitinib for the treatment of rheumatoid arthritisRoberto Caporali, Daniela Zavaglia
Nature Reviews. Rheumatology|January 12, 2024
Proposals for the rheumatological use of JAK inhibitorsFrancesco Ciccia, Roberto Caporali
Open Access Rheumatology : Research and Reviews|August 5, 2021
Tofacitinib: Real-World Data and Treatment Persistence in Rheumatoid ArthritisIlaria Bertoldi, Roberto Caporali
Clinical and Experimental Rheumatology|July 7, 2012
Predicting and managing the progression of structural damage in rheumatoid arthritis: where do we stand?Marcello Govoni, Roberto Caporali
Arthritis Care & Research|April 5, 2013
Therapeutic options in anti-jo-1 antisynthetase syndrome with interstitial lung disease: comment on the article by Marie et alLorenzo Cavagna, Roberto Caporali
Annals of the Rheumatic Diseases|August 4, 2017
Back to the future: forget ultrasound and focus on clinical assessment in rheumatoid arthritis managementRoberto Caporali, Josef S Smolen
The Lancet. Rheumatology|February 1, 2021
GM-CSF in the treatment of COVID-19: a new conductor in the pathogenesis of cytokine storm?Ennio Giulio Favalli, Roberto Caporali
Rheumatology (Oxford, England)|April 8, 2022
Controversies in rheumatology: ultrasound for monitoring of RA-do we need it?Hilde Berner Hammer, Roberto Caporali
BMJ (Clinical Research Ed.)|April 29, 2020
Managing patients with rheumatic conditions during the covid-19 pandemicRoberto Caporali, Ennio Giulio Favalli
Pageof 42

Showing results (1-10 of 416) with videos related to

Sort By:
Pageof 42
Nature Reviews. Rheumatology|April 2, 2024
Author Correction: Proposals for the rheumatological use of JAK inhibitorsFrancesco Ciccia, Roberto Caporali
Clinical and Experimental Rheumatology|September 6, 2018
Real-world experience with tofacitinib for the treatment of rheumatoid arthritisRoberto Caporali, Daniela Zavaglia
Nature Reviews. Rheumatology|January 12, 2024
Proposals for the rheumatological use of JAK inhibitorsFrancesco Ciccia, Roberto Caporali
Open Access Rheumatology : Research and Reviews|August 5, 2021
Tofacitinib: Real-World Data and Treatment Persistence in Rheumatoid ArthritisIlaria Bertoldi, Roberto Caporali
Clinical and Experimental Rheumatology|July 7, 2012
Predicting and managing the progression of structural damage in rheumatoid arthritis: where do we stand?Marcello Govoni, Roberto Caporali
Arthritis Care & Research|April 5, 2013
Therapeutic options in anti-jo-1 antisynthetase syndrome with interstitial lung disease: comment on the article by Marie et alLorenzo Cavagna, Roberto Caporali
Annals of the Rheumatic Diseases|August 4, 2017
Back to the future: forget ultrasound and focus on clinical assessment in rheumatoid arthritis managementRoberto Caporali, Josef S Smolen
The Lancet. Rheumatology|February 1, 2021
GM-CSF in the treatment of COVID-19: a new conductor in the pathogenesis of cytokine storm?Ennio Giulio Favalli, Roberto Caporali
Rheumatology (Oxford, England)|April 8, 2022
Controversies in rheumatology: ultrasound for monitoring of RA-do we need it?Hilde Berner Hammer, Roberto Caporali
BMJ (Clinical Research Ed.)|April 29, 2020
Managing patients with rheumatic conditions during the covid-19 pandemicRoberto Caporali, Ennio Giulio Favalli
Pageof 42